CVS Earnings Track Record: A Pattern of Beats With a Positive Drift
Over the last eight reported quarters, CVS has beaten analyst estimates in seven of them, for an 88% beat rate. The average earnings surprise across that stretch is 14%. The day-one price reaction, however, has not been uniform. The most recent print on 2026-05-06 produced an actual EPS of $2.57 against a $2.18 estimate, a 17.9% beat, yet the stock rose only 0.58% the next session. Three months earlier, on 2026-02-10, a 9% surprise on actual EPS of $1.09 versus a $1.00 estimate lifted the stock 1.85% the next day. The 2025-10-29 quarter showed that a beat is not the same as a rally: actual EPS of $1.60 versus $1.37, a 16.8% surprise, was followed by a next-day decline of 4.85%. Over the longer five-trading-day window, the average post-earnings move is 3.9%, with the drift direction classified as up. That upward drift is heavily influenced by the 12.95% move recorded after the May 2026 report, while the October 2025 quarter delivered a -2.54% five-day performance.
Options-Flow Dynamics Into the 2026-08-05 Report
CVS is scheduled to report before the open on 2026-08-05, with the consensus EPS estimate at $1.86. The stock was last priced at $105.21, sitting above the 50-day EMA of $101.10 and an RSI of 50.7. In the run-up to an event, options-market pricing reflects the market's real expectation for both the size and direction of the move, while dealers adjust hedges around the strike map. Because CVS's post-earnings drift has averaged 3.9% over five sessions, open interest around strikes 3% to 5% away from spot can act as magnets or barriers once the number is out. Gamma positioning into the print also matters: if dealers are net long gamma, volatility around the result may be dampened as they hedge; if they are net short gamma, moves can be amplified. Traders should monitor where implied volatility is priced relative to prior events and whether the flow skew is demanding calls or puts, since that mirrors the positioning that has to unwind after the release.
What a Disciplined Trader Watches After the Print
A disciplined approach treats the 88% beat rate and 14% average surprise as historical context, not a prediction. If CVS reports above the $1.86 consensus, the immediate question is whether the market already priced in the beat, as occurred on 2026-05-06 or 2025-07-31, when the stock gained 0.58% and 0.60% respectively despite beat margins of 17.9% and 24%. The 50-day EMA at $101.10 is a useful reference because a post-earnings gap below that level would break the short-term trend, while holding above $105.21 keeps the technical structure intact. Momentum traders can watch the RSI 50.7 reading for confirmation or divergence. Finally, the five-day window is where the 3.9% upward drift has historically shown up, so a post-report fade in either direction is worth tracking through the close of August 7 rather than judging on the first tick. For a deeper dive into how institutional desks are positioned and what the broader sell-side consensus looks like heading into the report, see the full institutional verdict on the ticker page.
Frequently Asked Questions
What is CVS's earnings beat rate over the last eight quarters?
CVS has beaten analyst estimates in seven of the last eight reported quarters, a beat rate of 88%, with an average earnings surprise of 14%.
When does CVS report next and what is the consensus EPS estimate?
CVS is scheduled to report before the open on 2026-08-05, and the consensus EPS estimate is $1.86.
How has CVS moved in the days following recent earnings reports?
Across the last eight quarters, the average five-day post-earnings move is 3.9%, classified as an upward drift. Recent examples include a 12.95% five-day gain after the 2026-05-06 report, a 2.82% gain after 2026-02-10, a 2.38% gain after 2025-07-31, and a 2.54% decline after 2025-10-29.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-05-06 | $2.57 | $2.18 | +17.9% | +0.58% | +12.95% |
| 2026-02-10 | $1.09 | $1 | +9% | +1.85% | +2.82% |
| 2025-10-29 | $1.6 | $1.37 | +16.8% | -4.85% | -2.54% |
| 2025-07-31 | $1.81 | $1.46 | +24% | +0.6% | +2.38% |
| 2025-05-01 | $2.25 | $1.7 | +32.4% | - | - |
| 2025-02-12 | $1.19 | $0.914 | +30.2% | - | - |
Previous CVS editions
Get the institutional verdict on CVS
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the CVS verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.